Sensorion

Sensorion Treasury Stock

The Treasury Stock of Sensorion (ALSEN.PA) as of Nov 18, 2026 is 78.77 M EUR. In the previous year, Treasury Stock was 104.00 M EUR — a change of -24.26% (lower).

Treasury Stock

78.77 MEUR

YoY

-24.26%

Last updated:

Treasury Stock of Sensorion is 2025 78.77 M EUR. Treasury Stock of Sensorion was 2024 104.00 M EUR. It decreases by -24.26% lower compared to the previous year.

The Sensorion Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2018
40.35 M EUR
Jan 1, 2019
24.58 M EUR
Jan 1, 2020
58.99 M EUR
Jan 1, 2021
50.46 M EUR
Jan 1, 2022
50.66 M EUR
Jan 1, 2023
36.54 M EUR
Jan 1, 2024
104.00 M EUR
Jan 1, 2025
78.77 M EUR
The Sensorion Treasury Stock history
YEARTreasury StockYoY
78.77 MEUR-24.26%
104.00 MEUR+184.59%
36.54 MEUR-27.87%
50.66 MEUR+0.39%
50.46 MEUR-14.45%
58.99 MEUR+139.99%
24.58 MEUR-39.09%
40.35 MEUR+23.95%
32.55 MEUR+25.78%
25.88 MEUR+13.68%
22.77 MEUR+156.47%
8.88 MEUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sensorion Stock analysis

What does Sensorion do? The company Sensorion SA is a French biotechnology company that specializes in developing innovative therapies for hearing and balance disorders. It was founded in 2009 and is headquartered in Montpellier. Sensorion SA's business model is based on researching and developing new drugs that can be used to treat inner ear diseases. These diseases often have severe effects on the quality of life and social interaction of those affected and represent a significant unmet medical need. Sensorion SA aims to develop innovative and effective therapies to address this need. The company specializes in two main areas: hearing disorders and balance disorders. In the field of hearing disorders, Sensorion SA focuses on developing drugs to treat sensorineural hearing loss. These disorders can be caused by various factors such as aging, noise exposure, or genetic predisposition and affect the inner ear. Sensorion SA has a promising pipeline of drugs in clinical development based on different mechanisms of action. These drugs aim to protect the inner ear and restore hearing function. In the field of balance disorders, Sensorion SA focuses on developing new drugs to treat dizziness and vestibular disorders. These disorders can be caused by factors such as aging, medications, or neurological diseases and affect the balance system in the inner ear. Sensorion SA also has a promising pipeline of drugs in clinical development in this area. Sensorion SA's products are not yet available on the market as they are still in development and undergoing clinical trials. However, the company works closely with academic and industry partners to test and validate its drugs. The development of new drugs is a lengthy and costly process that can take many years. However, Sensorion SA is confident that its therapies have the potential to improve the lives of many people. Overall, Sensorion SA has a promising business model based on the development of innovative therapies for hearing and balance disorders. The company has a promising pipeline of drugs in clinical development and works closely with partners to test and validate its products. If successful, their drugs could have a significant impact on the lives of people suffering from these diseases. Sensorion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sensorion stock

Treasury Stock of Sensorion is 78.77 M EUR in 2025.

Treasury Stock of Sensorion changed from 104.00 M EUR to 78.77 M EUR, representing a -24.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Sensorion since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Sensorion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sensorion

All Key Metrics — Sensorion